Patient Diversity in Global Industry Clinical Trials: Why It Matters, Who Should Be Concerned, and What Can Be Done?
<p id="p1">In their recent guidance to the industry the US FDA stated that it is concerned proposed the industry is rightfully concerned about patient diversity in industry-sponsored clinical trials (iCTs) due to a lack of attention on enrollment of representative numbers of participants from underr...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2023
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/1121596 |
| Tags: |
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!